The New York Times recently published a report highlighting potential side effects associated with the “Longevity Mix” sold by anti-aging tech entrepreneur Bryan Johnson, founder of the dietary supplement company Blueprint. The report, focusing primarily on Johnson’s use of confidentiality agreements, also revealed findings from an internal Blueprint study that examined the mix’s impact on users.
The Times article details how Johnson has utilized confidentiality agreements with employees, partners, and contractors, sometimes in exchange for settlements or continued employment. Three former employees have filed complaints with the National Labor Relations Board, alleging that Johnson’s agreements are overly broad and violate federal laws protecting workers’ rights to discuss workplace conditions.
Beyond the confidentiality agreements, the Times obtained information about an internal study conducted by Blueprint on the effects of its “Longevity Mix.” The results suggest a significant number of users experienced adverse reactions.
Internal documents, including emails and spreadsheets, indicate that approximately 60% of the study’s 1,700 participants reported at least one side effect. Blood tests revealed decreased testosterone levels and a shift toward prediabetes in participants following Johnson’s dietary plan. The severity of these side effects remains unclear.
One Blueprint employee noted in an internal communication that there were “a lot of comments about hating [the Longevity Mix] as it is making them sick, vomit, have heartburn, etc.” Allulose, a sugar alternative ingredient promoted by Johnson on social media, also reportedly caused problems, with numerous users reporting nausea and bloating.
Johnson responded to the New York Times report on X, characterizing it as a failed attempt at a “takedown” that ultimately read like a “profile piece.” He claimed the newspaper “came up empty” and resorted to “contorting and twisting facts.”
The article also touches on the broader controversy surrounding Johnson’s approach to anti-aging and the legal challenges he faces. While Johnson maintains the study results reflect common side effects associated with any food, beverage, or supplement, the Times report raises questions about the efficacy and safety of the “Longevity Mix.”
MaagX.com has contacted Blueprint for comment, acknowledging their typical response time of 1-2 business days. We have also reached out to the National Labor Relations Board for further information.
This situation underscores the importance of transparency and thorough testing in the dietary supplement industry, especially as interest in longevity and anti-aging solutions continues to grow. It also highlights the potential risks associated with restrictive confidentiality agreements and their impact on employee rights and public discourse.
